Translocator protein (18 kDa) polymorphism (rs6971) explains in-vivo brain binding affinity of the PET radioligand [(18)F]-FEPPA.
about
Neuroinflammation and brain atrophy in former NFL players: An in vivo multimodal imaging pilot studyProtein structure. Structure and activity of tryptophan-rich TSPO proteinsNIH workshop on clinical translation of molecular imaging probes and technology--meeting report.Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.Determination of [(11)C]PBR28 binding potential in vivo: a first human TSPO blocking study.Regional brain distribution of translocator protein using [(11)C]DPA-713 PET in individuals infected with HIV.Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging.Synthesis and evaluation of translocator 18 kDa protein (TSPO) positron emission tomography (PET) radioligands with low binding sensitivity to human single nucleotide polymorphism rs6971.Development of N-methyl-(2-arylquinolin-4-yl)oxypropanamides as leads to PET radioligands for translocator protein (18 kDa).Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes.Effect of Cigarette Smoking on a Marker for Neuroinflammation: A [11C]DAA1106 Positron Emission Tomography Study.Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA.Image derived input function for [18F]-FEPPA: application to quantify translocator protein (18 kDa) in the human brain.Minireview: translocator protein (TSPO) and steroidogenesis: a reappraisal.Imaging Striatal Microglial Activation in Patients with Parkinson's Disease.Feasibility study of TSPO quantification with [18F]FEPPA using population-based input functionA genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammationCerebrovascular and microglial states are not altered by functional neuroinflammatory gene variant.Cerebellum Can Serve As a Pseudo-Reference Region in Alzheimer Disease to Detect Neuroinflammation Measured with PET Radioligand Binding to Translocator ProteinDevelopment of (18)F-labeled radiotracers for neuroreceptor imaging with positron emission tomographyMapping neuroinflammation in frontotemporal dementia with molecular PET imaging.Imaging Microglial Activation in Individuals at Clinical High Risk for Psychosis: an In Vivo PET Study with [18F]FEPPA.Microglial activation in Parkinson's disease using [18F]-FEPPA.Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging.Investigation of TSPO variants in schizophrenia and antipsychotic treatment outcomes.Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [18F]FEPPA.Inflammation in the Neurocircuitry of Obsessive-Compulsive Disorder.In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106.Are We Moving Closer to Noninvasive Imaging and Monitoring of Neonatal Anesthesia-induced Neurotoxicity?Quantitative imaging of neuroinflammation in human white matter: a positron emission tomography study with translocator protein 18 kDa radioligand, [18F]-FEPPA.Whole body biodistribution and radiation dosimetry in humans of a new PET ligand, [(18)F]-FEPPA, to image translocator protein (18 kDa).Translocator protein ligands based on N-methyl-(quinolin-4-yl)oxypropanamides with properties suitable for PET radioligand development.Sifting through the surfeit of neuroinflammation tracers.Recent Progress in the Development of TSPO PET Ligands for Neuroinflammation Imaging in Neurological Diseases.Using molecular imaging to understand early schizophrenia-related psychosis neurochemistry: a review of human studies.Validation of an automatic reference region extraction for the quantification of [18F]DPA-714 in dynamic brain PET studies.In-vivo imaging of grey and white matter neuroinflammation in Alzheimer's disease: a positron emission tomography study with a novel radioligand, [18F]-FEPPA.Mitochondrial function in individuals at clinical high risk for psychosis.
P2860
Q28392661-79F34879-21DB-4F73-83E0-F720DD89188DQ28492337-D067D03E-6AC5-46D8-AF2B-7849EF8082A2Q30430958-8E710BE4-4C61-45C1-9AFC-0332A1645511Q31096423-96D44D70-6481-4C73-8B6B-1F2E194EA681Q33729262-D57F6530-2DCE-4440-8369-999837E99616Q33834306-CE472A2F-94D1-4DA0-8924-A52F9B8133C4Q33904501-A082C8E0-AE50-44E3-BD80-4CD6213C0881Q34408079-D5EDDF1F-73CB-4566-AF9A-39621B047469Q34435657-73A8A4D0-72DA-424E-9B77-7F7490E5F352Q34667721-8689135E-66C3-4202-BAB4-DAF6C0196AEDQ34680956-9EE4BBF8-8BAC-450B-BB17-D856A529A323Q34701163-32DD2AFA-836C-44C1-80C4-2D5F82A404F2Q34789872-0F5A499F-B0C8-49D5-B51B-B3E50074BFA7Q35441803-C9A54F14-5261-4793-8FF1-CCF5FA23E29DQ35779298-8C2B70CD-462E-4886-95D8-6572F9A823D9Q36381512-E5FDF619-FCE7-4F16-B240-DBFBA76B0FD6Q36684216-B63E780D-6C61-44C5-87E9-B84408C4CF96Q36765873-EFD8E4E3-484F-4AEF-8EEF-D97E5CA5A144Q36821286-C871CEA6-51E5-457F-8EF6-C05B8EDB00DFQ38244707-ADF57C7A-D05F-4B57-A4D8-EDDBC8AC421EQ38506602-41C9E473-0F10-46E1-818E-5B4F4B03A3E9Q38730353-50F46CCA-16A8-4755-B3F5-DDDE3FAD1916Q38770651-1E3D1F8D-7DA9-4D91-A29F-DC4347D16296Q38810544-9A1BF8B6-2CE1-4E5E-BDD2-D67706AE17D1Q39064271-442AFE85-7F72-48F8-A66F-1BB2149DCA8FQ39409090-DAA6A4CF-8B8E-48BD-AEB8-6B6A825C3046Q40163732-3EDD6C85-EF1D-404C-AF80-9289589358E2Q40275502-7617C97D-22B9-4C94-AB5C-FA67937BD6C7Q40842870-F8ED7A1D-E2CB-4E8C-A5CC-BBE122389F9EQ44837532-0331B829-370D-49CF-BA36-6A3ADC182C4BQ44951340-F8C811FA-1F94-482A-9F32-076E63EE2318Q46087990-5FDEAF9E-333C-4710-A28F-06A44A6FD6D9Q47277552-847E4033-BF04-4BBC-86FC-8C9B49C674D4Q47291761-6A756C64-4591-4DB1-9A4C-F79CDA91494DQ47566341-2E6A598C-715F-4AAF-BFF8-C942367DA6DCQ47979574-120CB1B5-8C49-4F7B-BB7A-B8155E17B12AQ48314517-3CAD1A15-5736-4E74-AAC4-5D8D3B91F371Q52316654-92636E44-E492-40A3-863A-7001E9E99D8A
P2860
Translocator protein (18 kDa) polymorphism (rs6971) explains in-vivo brain binding affinity of the PET radioligand [(18)F]-FEPPA.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Translocator protein (18 kDa) ...... PET radioligand [(18)F]-FEPPA.
@ast
Translocator protein (18 kDa) ...... PET radioligand [(18)F]-FEPPA.
@en
type
label
Translocator protein (18 kDa) ...... PET radioligand [(18)F]-FEPPA.
@ast
Translocator protein (18 kDa) ...... PET radioligand [(18)F]-FEPPA.
@en
prefLabel
Translocator protein (18 kDa) ...... PET radioligand [(18)F]-FEPPA.
@ast
Translocator protein (18 kDa) ...... PET radioligand [(18)F]-FEPPA.
@en
P2093
P2860
P50
P356
P1476
Translocator protein (18 kDa) ...... PET radioligand [(18)F]-FEPPA
@en
P2093
Alan A Wilson
Benoit Mulsant
Bruce Pollock
Ivonne Suridjan
James Kennedy
Vincenzo De Luca
P2860
P304
P356
10.1038/JCBFM.2012.46
P577
2012-04-04T00:00:00Z